pt141 drug PT-141 PT-141 Peptide Therapy for Enhanced

Drug Resist

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

The S-hexyl and S-2-iodobenzyl moieties of these product analogs bind in a pocket defined by side-chains from the beta1-alpha1 loop (Tyr7, Trp8, Ile10, Gly12, Leu13), helix alpha4 (Arg103, Tyr104, Ser107, Tyr111), and the C-terminal coil (Gln204, Gly205, Trp206, Gln207)

Therefore, the success of future research depends not only on in depth exploration of molecular mechanisms, but also on whether advanced drug delivery technologies (such as nano targeted drug delivery) and rational clinical design can cleverly utilize its mechanism of action while minimizing off target side effects